Use of deacylated chitin derivatives for the treatment of tumours of the haemopoietic system.

摘要

The present invention relates to a therapeutic agent composed of chitin for the treatment of tumors of blood cells, and more particularly relates to a therapeutic agent suitable for malignant tumors of blood cells, especially for diseases such as adult T-cell leukemia (ATL) and Sézary's syndrome. The present invention provides a therapeutic agent for blood cells tumors, countaining deacetylated chitin, preferably chitin with deacetylation of not less than 30%. The agent preferably contains at least 0.3% by weight, of deacetylated chitin.